Changes in health-related quality of life in common variable immunodeficiency: an eight-year journey, including the COVID-19 pandemic

References

• Jiang F, Torgerson TR, Ayars AG. Health-related quality of life in patients with primary immunodeficiency disease. Allergy, Asthma Clin Immunol. 2015 Dec;11(1):27. doi: 10.1186/s13223-015-0092-y
   PubMedGoogle Scholar
• Quinti I, Pulvirenti F. Health-related quality of life and patients’ empowerment in the health care of primary immune deficiencies. J Clin Immunol. 2017 Oct;37(7):615–616. doi: 10.1007/s10875-017-0428-0
   PubMed Web of Science ®Google Scholar
• Lindberg-Scharf P, Steinger B, Koller M, et al. Long-term improvement of quality of life in patients with breast cancer: supporting patient-physician communication by an electronic tool for inpatient and outpatient care. Support Care Cancer. 2021 Dec;29(12):7865–7875. doi: 10.1007/s00520-021-06270-1
   PubMed Web of Science ®Google Scholar
• Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984 Mar;2(3):187–193. doi: 10.1200/JCO.1984.2.3.187
   PubMed Web of Science ®Google Scholar
• Peshko D, Kulbachinskaya E, Korsunskiy I, et al. Health-related quality of life in children and adults with primary immunodeficiencies: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2019 Jul;7(6):1929–1957.e5. doi: 10.1016/j.jaip.2019.02.013
   PubMed Web of Science ®Google Scholar
• Bonilla FA, Barlan I, Chapel H, et al. International consensus document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016 Jan;4(1):38–59. doi: 10.1016/j.jaip.2015.07.025
   PubMed Web of Science ®Google Scholar
• Franzblau LE, Fuleihan RL, Cunningham-Rundles C, et al. CVID-associated iIntestinal disorders in the USIDNET registry: an analysis of disease manifestations, functional status, comorbidities, and treatment. J Clin Immunol. 2024 Jan;44(1):32. doi: 10.1007/s10875-023-01604-6
   Web of Science ®Google Scholar
• Pulvirenti F, Pecoraro A, Cinetto F, et al. Gastric cancer is the leading cause of death in Italian adult patients with common variable immunodeficiency. Front Immunol. 2018 Nov 5;9:2546. doi: 10.3389/fimmu.2018.02546
   PubMed Web of Science ®Google Scholar
• Correa-Jimenez O, Restrepo-Gualteros S, Nino G, et al. Respiratory comorbidities associated with bronchiectasis in patients with common variable immunodeficiency in the USIDNET Registry. J Clin Immunol. 2023 Nov;43(8):2208–2220. doi: 10.1007/s10875-023-01593-6
   PubMed Web of Science ®Google Scholar
• Jolles S, Orange JS, Gardulf A, et al. Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clin Exp Immunol. 2015 Jan 2;179(2):146–160. doi: 10.1111/cei.12485
   PubMed Web of Science ®Google Scholar
• Routes J, Costa-Carvalho BT, Grimbacher B, et al. Health-related quality of life and health resource utilization in patients with primary immunodeficiency disease prior to and following 12 months of immunoglobulin G Treatment. J Clin Immunol. 2016 Jul;36(5):450–461. doi: 10.1007/s10875-016-0279-0
   PubMed Web of Science ®Google Scholar
• Petersson C, Fust R, Hagstedt C, et al. “Experiences of the burden of treatment”—patient reports of facilitated subcutaneous immunoglobulin treatment in adults with immunodeficiency. J Clin Nurs. 2018 Dec;27(23–24):4270–4278. doi: 10.1111/jocn.14580
   PubMed Web of Science ®Google Scholar
• Padem N, Wright H, Fuleihan R, et al. Rheumatologic diseases in patients with inborn errors of immunity in the USIDNET registry. Clin Rheumatol. 2022 Jul;41(7):2197–2203. doi: 10.1007/s10067-021-06044-4
   PubMed Web of Science ®Google Scholar
• Quinti I, Di Pietro C, Martini H, et al. Health related quality of life in common variable immunodeficiency. Yonsei Med J. 2012;53(3):603. doi: 10.3349/ymj.2012.53.3.603
   PubMed Web of Science ®Google Scholar
• Tabolli S, Giannantoni P, Pulvirenti F, et al. Longitudinal study on health-related quality of life in a cohort of 96 patients with common variable immune deficiencies. Front Immunol [Internet]. 2014 Nov 26 [cited 2024 Jan 19];5. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2014.00605/abstract
   PubMed Web of Science ®Google Scholar
• Pulvirenti F, Cinetto F, Pecoraro A, et al. Health-related quality of life in patients with CVID under different schedules of immunoglobulin administration: prospective multicenter study. J Clin Immunol. 2019 Feb;39(2):159–170. doi: 10.1007/s10875-019-0592-5
   PubMed Web of Science ®Google Scholar
• Quinti I, Pulvirenti F, Giannantoni P, et al. Development and initial validation of a questionnaire to measure health-related quality of life of adults with common variable immune deficiency: the CVID_QoL questionnaire. J Allergy Clin Immunol Pract. 2016 Nov;4(6):1169–1179.e4. doi: 10.1016/j.jaip.2016.07.012
   PubMed Web of Science ®Google Scholar
• Pulvirenti F, Cinetto F, Milito C, et al. Health-related quality of life in common variable immunodeficiency Italian patients switched to remote assistance during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020 Jun;8(6):1894–1899.e2. doi: 10.1016/j.jaip.2020.04.003
   PubMed Web of Science ®Google Scholar
• Ameratunga R, Brewerton M, Slade C, et al. Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front Immunol. 2014 Sep 15 [cited 2024 May 16];5. doi: 10.3389/fimmu.2014.00415
   PubMed Web of Science ®Google Scholar
• Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Clin Immunol. 1999 Dec;93(3):190–197. doi: 10.1006/clim.1999.4799
   PubMed Web of Science ®Google Scholar
• Piano Mortari E, Pulvirenti F, Marcellini V, et al. Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters. Front Immunol. 2023 May 25;14:1194225. doi: 10.3389/fimmu.2023.1194225
   PubMed Web of Science ®Google Scholar
• Hurst JR, Verma N, Lowe D, et al. British lung foundation/United Kingdom primary immunodeficiency network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2017 Jul;5(4):938–945. doi: 10.1016/j.jaip.2017.01.021
   PubMed Web of Science ®Google Scholar
• Braido F, Santus P, Corsico A, et al. Chronic obstructive lung disease “expert system”: validation of a predictive tool for assisting diagnosis. Int J Chron Obstruct Pulmon Dis. 2018 May;13:1747–1753. doi: 10.2147/COPD.S165533
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematol Am Soc Hematol Educ Program. 2012;2012(1):301–305. doi: 10.1182/asheducation.V2012.1.301.3798316
   PubMedGoogle Scholar
• Johnstone A, Goldberg D. Psychiatric screening in general practice. Lancet. 1976 Mar;307(7960):605–608. doi: 10.1016/S0140-6736(76)90415-3
   Google Scholar
• Resnick ES, Moshier EL, Godbold JH, et al. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012 Feb 16;119(7):1650–1657. doi: 10.1182/blood-2011-09-377945
   PubMed Web of Science ®Google Scholar
• Barlogis V, Mahlaoui N, Auquier P, et al. Burden of poor health conditions and quality of life in 656 children with primary immunodeficiency. J Pediatr. 2018 Mar;194:211–217.e5. doi: 10.1016/j.jpeds.2017.10.029
   PubMed Web of Science ®Google Scholar
• Barlogis V, Mahlaoui N, Auquier P, et al. Physical health conditions and quality of life in adults with primary immunodeficiency diagnosed during childhood: a French reference center for PIDs (CEREDIH) study. J Allergy Clin Immunol. 2017 Apr;139(4):1275–1281.e7. doi: 10.1016/j.jaci.2016.08.027
   PubMed Web of Science ®Google Scholar
• Ridao-Manonellas S, Fábregas-Bofill A, Núñez-Rueda G, et al. Health-related quality of life and multidimensional fatigue scale in children with primary immunodeficiencies. J Clin Immunol. 2020 May;40(4):602–609. doi: 10.1007/s10875-020-00775-w
   PubMed Web of Science ®Google Scholar
• Espanol T, Olding L, Prevot J, et al. Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment. Patient Prefer Adherence. 2014 May;621. doi: 10.2147/PPA.S60771
   PubMed Web of Science ®Google Scholar
• Rider NL, Kutac C, Hajjar J, et al. Health-related quality of life in adult patients with common variable immunodeficiency disorders and impact of treatment. J Clin Immunol. 2017 Jul;37(5):461–475. doi: 10.1007/s10875-017-0404-8
   PubMed Web of Science ®Google Scholar
• Zebracki K, Palermo TM, Hostoffer R, et al. Health-related quality of life of children with primary immunodeficiency disease: a comparison study. Ann Allergy Asthma Immunol. 2004 Dec;93(6):557–561. doi: 10.1016/S1081-1206(10)61263-X
   PubMed Web of Science ®Google Scholar
• Anderson JT, Cowan J, Condino-Neto A, et al. Health-related quality of life in primary immunodeficiencies: impact of delayed diagnosis and treatment burden. Clin Immunol. 2022 Mar;236:108931. doi: 10.1016/j.clim.2022.108931
   PubMed Web of Science ®Google Scholar
• Fried AJ, Bonilla FA. Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev. 2009 Jul;22(3):396–414. doi: 10.1128/CMR.00001-09
   PubMed Web of Science ®Google Scholar
• Zhang S, Kline M, Fuleihan RL, et al. PROMIS-29 survey confirms major impact of fatigue on health-related quality of life in common variable immunodeficiency. Immunol Res. 2020 Dec;68(6):379–388. doi: 10.1007/s12026-020-09162-4
   PubMed Web of Science ®Google Scholar
• Kumar Y, Bhatia A. Common variable immunodeficiency in adults: current diagnostic protocol and laboratory measures. Expert Rev Clin Immunol. 2013 Oct;9(10):959–977. doi: 10.1586/1744666X.2013.836967
   PubMed Web of Science ®Google Scholar
• Cella D, Yount S, Rothrock N, et al. The patient-reported outcomes measurement information system (PROMIS): progress of an nih roadmap cooperative group during its first two years. Med care. 2007 May;45(5):S3–11. doi: 10.1097/01.mlr.0000258615.42478.55
   PubMed Web of Science ®Google Scholar
• Berger M, Murphy E, Riley P, et al. Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G. South Med J. 2010 Sep;103(9):856–863. doi: 10.1097/SMJ.0b013e3181eba6ea
   PubMed Web of Science ®Google Scholar
• Jones GL, Vogt KS, Chambers D, et al. What is the burden of immunoglobulin replacement therapy in adult patients with primary immunodeficiencies? a systematic review. Front Immunol. 2018 Jul 2;9:1308. doi: 10.3389/fimmu.2018.01308
   PubMed Web of Science ®Google Scholar
• Bienvenu B, Cozon G, Mataix Y, et al. Rapid push vs pump-infused subcutaneous immunoglobulin treatment: a randomized crossover study of quality of life in primary immunodeficiency patients. J Clin Immunol. 2018 May;38(4):503–512. doi: 10.1007/s10875-018-0507-x
   PubMed Web of Science ®Google Scholar
• Mallick R, Jolles S, Kanegane H, et al. Treatment satisfaction with subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency: a pooled analysis of six hizentra® Studies. J Clin Immunol. 2018 Nov;38(8):886–897. doi: 10.1007/s10875-018-0562-3
   PubMed Web of Science ®Google Scholar
• Perez EE, Orange JS, Bonilla F, et al. Update on the use of immunoglobulin in human disease: a review of evidence. J Allergy Clin Immunol. 2017 Mar;139(3):S1–46. doi: 10.1016/j.jaci.2016.09.023
   PubMed Web of Science ®Google Scholar
• Milito C, Pulvirenti F, Cinetto F, et al. Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies. J Allergy Clin Immunol. 2019 Aug;144(2):584–593.e7. doi: 10.1016/j.jaci.2019.01.051
   PubMed Web of Science ®Google Scholar
• ŞahiN ME, Satar S, Ergün P. Long-term efficiency of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease, bronchiectasis, and asthma: does it differ? Turk J Med Sci. 2023 Jan 1;53(3):814–823. doi: 10.55730/1300-0144.5644
   PubMed Web of Science ®Google Scholar
• Poudel AN, Zhu S, Cooper N, et al. Impact of Covid-19 on health-related quality of life of patients: a structured review. Mitra P, editor. PLOS ONE. 2021 Oct 28;16(10):e0259164. doi: 10.1371/journal.pone.0259164
   PubMed Web of Science ®Google Scholar
• Pensieri MV, Pulvirenti F, Schiepatti A, et al. The high mortality of patients with common variable immunodeficiency and small bowel villous atrophy. Scand J Gastroenterol. 2019 Feb 1;54(2):164–168. doi: 10.1080/00365521.2019.1568543
   PubMed Web of Science ®Google Scholar
• Milito C, Pulvirenti F, Garzi G, et al. Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022. Front Immunol. 2023 Oct 6;14:1231242. doi: 10.3389/fimmu.2023.1231242
   PubMed Web of Science ®Google Scholar
• Garzi G, Cinetto F, Firinu D, et al. Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic. Front Immunol. 2022;13:947174. doi: 10.3389/fimmu.2022.947174
   PubMed Web of Science ®Google Scholar
• Milito C, Cinetto F, Palladino A, et al. Mortality in severe antibody deficiencies patients during the first two years of the COVID-19 Pand-emic: vaccination and monoclonal antibodies efficacy. Biomedicines. 2022 Apr 29;10(5):1026. doi: 10.3390/biomedicines10051026
   PubMed Web of Science ®Google Scholar